Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GNPAT | O15228 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7520216 | 0.92 | TRPV1 (0.40) | TRPV1CHRM2CHRM4CHRM1KDM4E | |
| SCHEMBL12478006 | 0.81 | PLA2G2C (0.46) | SIRT6SIRT1PLA2G2C | |
| SCHEMBL17213387 | 0.79 | SIRT6 (0.47) | SIRT6SIRT1PLA2G2C | |
| SCHEMBL7801151 | 0.78 | SIRT6 (0.50) | TRPV1SIRT6SIRT1 | |
| SCHEMBL7085362 | 0.76 | — | — | |
| Benzene SCHEMBL9177693 | 0.73 | SIRT6 (0.43) | MAPTALDH1A1SIRT6SIRT1PLA2G2C | |
| SCHEMBL5596648 | 0.72 | GABRP (0.52) | MAPTNFKB1BLMGNPATPLA2G2C | |
| SCHEMBL28663197 | 0.72 | MTNR1A (0.41) | ALDH1A1 | |
| SCHEMBL24158519 | 0.72 | ALOX15 (0.37) | KDM4EALOX15SMN1; SMN2SIRT6SIRT1 | |
| SCHEMBL20892574 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0497525-B2 | Pneumococcal polysaccharide conjugate vaccine | MERCK & CO INC (US) | 2010-03-03 | — | — | EP | disclosed |
| EP-0497525-B1 | Pneumococcal polysaccharide conjugate vaccine | MERCK & CO INC (US) | 1998-08-19 | — | — | EP | disclosed |
| US-5623057-A | IMMUNOGENIC PROTEIN COVALENTLY LINKED TO POLYSACCHARIDE DERIVED FROM STREPTOCOCCUS PNEUMONIAE | MERCK & CO., INC. (US) | 1997-04-22 | — | — | US | disclosed |
| US-5371197-A | Protein-dimeric polysaccharide conjugate vaccine | MERCK & CO., INC. (US) | 1994-12-06 | — | — | US | disclosed |
| EP-0534764-A1 | Protein-dimeric polysaccharide conjugate vaccine | MERCK & CO. INC. (US) | 1993-03-31 | — | — | EP | disclosed |
| EP-0497525-A2 | Pneumococcal polysaccharide conjugate vaccine | MERCK & CO. INC. (US) | 1992-08-05 | — | — | EP | disclosed |
| EP-0186576-B1 | COVALENTLY-MODIFIED NEUTRAL BACTERIAL POLYSACCHARIDES, STABLE COVALENT CONJUGATES OF SUCH POLYSACCHARIDES AND IMMUNOGENIC PROTEINS, AND METHODS OF PREPARING SUCH POLYSACCHARIDES AND CONJUGATES | MERCK & CO. INC. (US) | 1992-07-22 | — | — | EP | disclosed |
| EP-0467714-A1 | The class II protein of the outer membrane of neisseria meningitidis | MERCK & CO. INC. (US) | 1992-01-22 | — | — | EP | disclosed |
| EP-0161188-B1 | COVALENTLY-MODIFIED BACTERIAL POLYSACCHARIDES, STABLE COVALENT CONJUGATES OF SUCH POLYSACCHARIDES AND IMMUNOGENIC PROTEINS WITH BIGENERIC SPACERS, AND METHODS OF PREPARING SUCH POLYSACCHARIDES AND CONJUGATES AND OF CONFIRMING COVALENCY | MERCK & CO. INC. (US) | 1991-04-03 | — | — | EP | disclosed |
| US-4882317-A | SOLUBILIZATION | MERCK & CO., INC. (US) | 1989-11-21 | — | — | US | disclosed |
| US-4830852-A | COVALENT-MODIFICATION AND HAVING A COUPLING SPACER CONTAINING A THIOETHER; VACCINES; CHEMICAL STABILITY; INFANT PROTECTION | MERCK & CO INC. (US) | 1989-05-16 | — | — | US | disclosed |
| US-4695624-A | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency | MERCK & CO., INC. (US) | 1987-09-22 | — | — | US | disclosed |
| EP-0186576-A2 | Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates | MERCK & CO. INC. (US) | 1986-07-02 | — | — | EP | disclosed |
| EP-0161188-A2 | Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency | MERCK & CO. INC. (US) | 1985-11-13 | — | — | EP | disclosed |